calamine

Calamine is a private biotechnology company dedicated to the discovery and development of innovative treatments for dermatological and inflammatory diseases. Founded with backing from ARCH Venture Partners, the company focuses on addressing high unmet needs in conditions such as atopic dermatitis and chronic pruritus. Calamine utilizes advanced research in skin immunology to identify novel targets and develop therapies that offer superior clinical outcomes compared to existing standards of care. The company's leadership includes experienced veterans from the biotechnology and pharmaceutical industries, many of whom have successful track records in the dermatology space. Currently in the pre-clinical stage, Calamine is advancing a pipeline of small molecule and biologic candidates designed for both systemic and targeted delivery.